Phio Pharmaceuticals Corp. (PHIO) Financials

$2.38

$0.03 (-1.25%)
Last update: 04:00 PM EST
Day's range
$2.33
Day's range
$2.41
$5M$5M$0$0-$5M-$5M-$10M-$10M-$15M-$15MEarning201820182019201920202020202120212022202220232023202420240%0%-20000%-20000%-40000%-40000%-60000%-60000%-80000%-80000%Profit Margin
Profit Margin
Revenue
Earnings

PHIO Income statement / Annual

Last year (2024), Phio Pharmaceuticals Corp.'s total revenue was $0.00, and the percentage change from the previous year is not available. In 2024, Phio Pharmaceuticals Corp.'s net income was -$7.15 M. See Phio Pharmaceuticals Corp.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $21.00 K $138.00 K $15.00 K $19.00 K $34.00 K
Cost of Revenue $35.00 K $6.33 M $193.00 K $192.00 K $183.00 K $4.30 K $4.33 M $5.37 M $5.42 M $6.93 M
Gross Profit $0.00 -$6.33 M -$193.00 K -$192.00 K -$183.00 K $16.70 K -$4.19 M -$5.36 M -$5.40 M -$6.89 M
Gross Profit Ratio 0 0 0 0 0 0.8 -30.35 -357 -284 -202.68
Research and Development Expenses $3.64 M $6.33 M $7.01 M $8.89 M $4.43 M $4.30 M $4.33 M $5.37 M $5.42 M $6.93 M
General & Administrative Expenses $3.74 M $4.29 M $4.45 M $4.63 M $4.36 M $4.71 M $3.18 M $4.01 M $3.62 M $3.35 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $3.74 M $4.29 M $4.45 M $4.63 M $4.36 M $4.71 M $3.18 M $4.01 M $3.62 M $3.35 M
Other Expenses $0.00 -$6.13 M -$18.00 K $224.00 K -$1.00 K $79.00 K $4.00 K $4.70 M $3.11 M $2.44 M
Operating Expenses $7.39 M $4.49 M $11.46 M $13.51 M $8.79 M $9.01 M $7.50 M $9.38 M $9.03 M $10.27 M
Cost And Expenses $0.00 $10.82 M $11.46 M $13.51 M $8.79 M $9.01 M $7.50 M $9.38 M $9.03 M $10.27 M
Interest Income $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Interest Expense $231.00 K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Depreciation & Amortization $35.00 K $184.00 K $193.00 K $192.00 K $183.00 K $67.00 K $81.00 K $70.00 K $53.00 K $77.00 K
EBITDA -$7.12 M -$10.64 M -$11.29 M -$13.09 M -$8.72 M -$8.92 M -$7.28 M -$14.00 M -$8.96 M -$10.16 M
EBITDA Ratio 0 0 0 0 0 -424.76 -52.78 -933.53 -471.68 -298.82
Operating Income Ratio 0 0 0 0 0 -427.95 -53.36 -937.47 -474.47 -301.09
Total Other Income/Expenses Net $237.00 K -$2.00 K -$18.00 K $224.00 K -$1.00 K $79.00 K $4.00 K -$11.00 K $21.00 K $14.00 K
Income Before Tax -$7.15 M -$10.83 M -$11.48 M -$13.29 M -$8.79 M -$8.91 M -$7.36 M -$14.07 M -$8.99 M -$10.22 M
Income Before Tax Ratio 0 0 0 0 0 -424.19 -53.33 -938.2 -473.37 -300.68
Income Tax Expense $0.00 $0.00 -$175.00 K -$75.00 K $0.00 -$67.00 K $4.00 K -$1.62 M -$74.00 K -$91.00 K
Net Income -$7.15 M -$10.83 M -$11.31 M -$13.21 M -$8.79 M -$8.84 M -$7.36 M -$12.45 M -$8.99 M -$10.22 M
Net Income Ratio 0 0 0 0 0 -421 -53.33 -830.13 -473.37 -300.68
EPS -0.91 -46.87 -89.61 -111.32 -207.25 -2074.18 -6218.35 -32801.22 -79282.81 -93029.39
EPS Diluted -0.91 -46.76 -89.61 -111.32 -207.25 -2074.18 -6218.35 -32801.22 -79282.81 -93029.39
Weighted Average Shares Out $7.87 M $231.00 K $126.16 K $118.68 K $42.43 K $4.26 K $1.18 K $379.62 $113.44 $109.89
Weighted Average Shares Out Diluted $7.87 M $231.51 K $126.16 K $118.68 K $42.43 K $4.26 K $1.18 K $379.62 $113.44 $109.89
Link